arrow
BackJournal Details
D

Drugs in R&D

IF2.1
Papers18
Citations1230
Journal Papers 18
Publication Date
Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular Mechanisms
delete2026-04-01
delete0
PREAI
deleteJiang, Hua; Xu, Mingzhen; Jiang, Songsong; Huang, Weiqiang
deleteShare
deleteSave
HIF-1α siRNA Enhances the Efficacy of Erlotinib in Non-small Cell Lung Cancer: A Novel Strategy to Reverse Hypoxia-Induced Drug Resistance
delete2026-04-01
delete0
PREAI
deleteJiang, Haojie; Cai, Shunhui; Zhang, Xiaojun; Chen, Shijie; Yue, Chunyan; Yin, Wu; Hu, Yiqiao
deleteShare
deleteSave
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies
delete2026-03-01
delete0
PREAI
deleteChoi, Heejae; Madari, Shilpa; Daalman, Elmar; English, Brett A.; Halabi, Atef; Hohl, Kathrin; Shatillo, Yury; Weidinger, Nathalie; Desch, Michael
deleteShare
deleteSave
Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam
delete2026-03-01
delete1
PREAI
deleteLiu, Yang; Shi, Qiong-zhi; Wang, Yanchen; Long, Ze-chun; Han, Man; Zeng, Yuan; Xie, Xiang-yang; Liu, Hui
deleteShare
deleteSave
Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema
delete2026-03-01
delete1
PREAI
deleteAndresen, Irmgard; Khutoryansky, Natalie; Feeny, Sarah L.; Dangel, Alissa
deleteShare
deleteSave
Omadacycline Pharmacokinetics: Characteristics, Contributing Factors, and Clinical Significance
delete2025-12-01
delete0
deleteOAAI
deleteSun, Huan; Hou, Xiaoli; Zhu, Qiuzhen; Liu, Juan; Zhai, Qiaoli; Shi, Kourong
deleteShare
deleteSave
Pharmacokinetics, Pharmacodynamics, and Safety of ET-26 in Subjects with Mild to Moderate Renal Impairment
delete2025-12-01
delete0
deleteOAAI
deleteYang, Fan; Shen, Chao-Zhuang; Ye, Pan-Pan; Lv, Wen-Shuo; Li, Li-Ze; Shao, Jie; Diao, Lei; Ke, Bo-Wen; Zheng, Yi; Yang, Xiao-Ran; Zhao, Wei
deleteShare
deleteSave
Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Omecamtiv Mecarbil in Healthy Chinese Subjects
delete2025-12-01
delete0
deleteOAAI
deleteLi, Xuening; Li, Hui; Xu, Hongrong; Yuan, Fei; Chen, Hanjing; Liu, Chao; Yang, Mengjie; Li, Jing; Sheng, Lei
deleteShare
deleteSave
Safety, Tolerability and Pharmacokinetics of a High-Dose, Rapid-Infusion Monoclonal Antibody: Phase I Results for Intravenous Sotrovimab 3000 mg
delete2025-12-01
delete0
deleteOAAI
deleteSanchez-Pearson, Yasmin; Moore, Jennifer; Daniluk, Jerzy; Bhangu, Sookti; Parra, Sergio; El Zailik, Asma; Sarkar, Prosenjit; Aylott, Alicia; Moyo, Farai; Peppercorn, Amanda; Skingsley, Andrew
deleteShare
deleteSave
Efficacy and Safety of Ulinastatin in Post-traumatic Sepsis: A Randomized Controlled Trial
delete2025-11-01
delete0
deleteOAAI
deleteYang, Ao; Liu, Rui; Lv, Kongbo; Chen, Weijun; Han, Mengfei; Yang, Zhizhou
deleteShare
deleteSave
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial
delete2025-11-01
delete0
deleteOAAI
deleteGupta, Anil; Perez-Rodriguez, Maria Teresa; Gonzalez-Rojas, Yaneicy; Ramgopal, Moti; Free, Almena; Han, Jennifer; Moore, Jennifer; Givens, Naomi; Yates, Phillip J.; Walker, Jill T.; Connolly, Mary Beth; Schnell, Gretja; Imber, Varsha; Anselm, Rabia; Winograd, Lindsay; Segal, Scott; Harrison, Stephen; Skingsley, Andrew; Aldinger, Melissa; Peppercorn, Amanda; Moya, Jaynier
deleteShare
deleteSave
Bioequivalence Study of Bedaquiline and Sirturo® in Healthy Chinese Subjects Under Fasting and Postprandial Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial
delete2025-10-01
delete0
deleteOAAI
deleteLi, Yixuan; Wu, Yi; Cai, Shufan; Huang, Xiangxin; Ye, Lijun; Wang, Lin; Zhang, Yingying; Wang, Ying; Tao, Xuexia
deleteShare
deleteSave
Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model
delete2025-09-01
delete0
deleteOAAI
deleteYu, Biao; Mei, Kangkang; Zhan, Didi; Tang, Qi; Cai, Heping; Zhang, Runcong
deleteShare
deleteSave
Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent
delete2008-01-01
delete4
PREAI
deleteMandhane, Sanjay N.; Ayer, Upendra B.; Midha, Ajay S.; Rao, Chitturi Trinadha; Rajamannar, Thennati
deleteShare
deleteSave